TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33137352

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Vigorous-intensity exercise
Number of subjects: 42

Group type: COMPARATOR
Intervention: No exercise (rest)
Number of subjects: 42
Study: 36056408

Group type: EXPERIMENTAL
Intervention: Repeat revealed PlGF-based testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Repeat concealed testing
Number of subjects: 0
Study: 34593565

Group type: EXPERIMENTAL
Intervention: Rucaparib monotherapy (600 mg orally twice a day)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Rucaparib plus nivolumab (600 mg orally twice a day + 480 mg intravenously every 4 weeks)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo (oral placebo + intravenous placebo)
Number of subjects: 1000
Study: 35522898

Group type: EXPERIMENTAL
Intervention: Deep learning-based model using texture features of myeloblast chromatin patterns to generate a risk score.
Number of subjects: 92
Study: 32111181

Group type: COMPARATOR
Intervention: Chemotherapy with docetaxel 75 mg/m2, cisplatin 75 mg/m2 followed by chemo‐radiotherapy (CRT)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Chemotherapy with docetaxel 75 mg/m2, cisplatin 75 mg/m2 followed by chemo‐radiotherapy (CRT) with addition of cetuximab
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Adenocarcinoma
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Squamous cell cancer
Number of subjects: 300
Study: 34678118

Group type: EXPERIMENTAL
Intervention: SP-CL stem
Number of subjects: 72

Group type: COMPARATOR
Intervention: Corail stem
Number of subjects: 72
Study: 33657192

Group type: EXPERIMENTAL
Intervention: Baveno VI criteria
Number of subjects: 839

Group type: EXPERIMENTAL
Intervention: Baveno VI criteria with albumin-related threshold
Number of subjects: 839
Study: 32868147

Group type: EXPERIMENTAL
Intervention: Rooming-in with family members
Number of subjects: 0
Study: 36137619

Group type: EXPERIMENTAL
Intervention: Home-based CCU and CRC screening intervention offered during breast cancer screening, including vaginal self-sampling kits for HPV testing and faecal immunochemical tests.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home-based CCU and CRC screening intervention offered during breast cancer screening.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care provided to women attending control units.
Number of subjects: 0
Study: 34294036

Group type: EXPERIMENTAL
Intervention: Multimodal comprehensive care methodology training programme for family caregivers (6 hours total, three sessions of 2 hours each over 3 months, followed by weekly information delivery via postcard)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Multimodal comprehensive care methodology training programme for family caregivers
Number of subjects: 148
Study: 32251216

Group type: EXPERIMENTAL
Intervention: Enhanced Recovery After Surgery (ERAS) protocol (N = 44)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Conventional care (CON) protocol (N = 41)
Number of subjects: 85
Study: 35182789

Group type: EXPERIMENTAL
Intervention: Remotely delivered weight loss intervention (22 counseling calls over 12 months)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Usual care (standard medical care and brief feedback)
Number of subjects: 159
Study: 33528020

Group type: EXPERIMENTAL
Intervention: Modified Incremental Step Test (MIST)
Number of subjects: 46
Study: 36111187

Group type: EXPERIMENTAL
Intervention: 30-frequency group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 60-frequency group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 15-frequency group
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 33826454

Group type: EXPERIMENTAL
Intervention: Modified Poisson regression with robust sandwich variance
Number of subjects: 10

Group type: COMPARATOR
Intervention: Log-binomial regression
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exchangeable working correlation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Independence working correlation
Number of subjects: 10
Study: 32234715

Group type: EXPERIMENTAL
Intervention: Tanezumab 5 mg
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5 mg
Number of subjects: 849

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 849
Study: 35559992

Group type: EXPERIMENTAL
Intervention: 1 g of azithromycin (standard of care)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No azithromycin
Number of subjects: 24
Study: 33961145

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Renin-angiotensin blockers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Steroid-free and mTOR-based immunosuppressive drug combinations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thiazide diuretics
Number of subjects: 0
Study: 32100679

Group type: EXPERIMENTAL
Intervention: Intervention group (RANAS model-based intervention delivered over 9 months)
Number of subjects: 320
Study: 34865858

Group type: EXPERIMENTAL
Intervention: Toy distraction method (music and movement)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study: 32382931

Group type: EXPERIMENTAL
Intervention: Porcine-derived acellular dermal matrix (MD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (SCTG)
Number of subjects: 18
Study: 35508035

Group type: EXPERIMENTAL
Intervention: Internal suture (group I)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: External suture (group II)
Number of subjects: 40
Study: 33913134

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 60
Study: 35876363

Group type: EXPERIMENTAL
Intervention: Supportive interventions for hospice family caregivers
Number of subjects: 525

Group type: COMPARATOR
Intervention: Demographic and contextual controls
Number of subjects: 525
Study: 34399583

Group type: EXPERIMENTAL
Intervention: Genome‐wide association studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mendelian randomization studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polygenic risk scores
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacogenomics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetics of stroke outcome
Number of subjects: 0
Study: 35025677

Group type: EXPERIMENTAL
Intervention: White students interacting with White standardized patients (SPs)
Number of subjects: 50

Group type: COMPARATOR
Intervention: White students interacting with Black standardized patients (SPs)
Number of subjects: 50
Study: 35320013

Group type: EXPERIMENTAL
Intervention: MS-10 treatment
Number of subjects: 71
Study: 32450083

Group type: EXPERIMENTAL
Intervention: Randomized Prisoner's Dilemma (RPD) game with independent payoffs for cooperation and defection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized matrix games with non-independent payoffs (RPD game with additive payoffs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated RPD game with Tit-for-Tat and Always-Defect strategies
Number of subjects: 0
Study: 35255832

Group type: EXPERIMENTAL
Intervention: COLM-SST (caraway oil and L-menthol)
Number of subjects: 600
Study: 32121000

Group type: EXPERIMENTAL
Intervention: Hb threshold <12.35 g/dL
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: WHO altitude-adjusted threshold <12.5 g/dL
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Unadjusted Hb cut-off <12 g/dL
Number of subjects: 492
Study: 33497295

Group type: EXPERIMENTAL
Intervention: Perineural bupivacaine infiltration (2 mL of 0.5% bupivacaine)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (spinal anaesthesia only)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 34633992

Group type: EXPERIMENTAL
Intervention: 0.5 mg·kg‐1 ketamine for 40 minutes
Number of subjects: 84

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 84
Study: 34020179

Group type: EXPERIMENTAL
Intervention: Isolated nasal surgery (septoplasty and inferior turbinate reduction)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Isolated nasal surgery
Number of subjects: 35
Study: 32024228

Group type: EXPERIMENTAL
Intervention: Visual aids showing total amount of sugar in drinks
Number of subjects: 261

Group type: COMPARATOR
Intervention: No sugar display (control condition)
Number of subjects: 261
Study: 33677450

Group type: EXPERIMENTAL
Intervention: Azilsartan 20 mg daily for 3 months
Number of subjects: 111

Group type: COMPARATOR
Intervention: Candesartan 8 mg daily for 3 months
Number of subjects: 111
Study: 33108379

Group type: EXPERIMENTAL
Intervention: Atole (protein-energy beverage)
Number of subjects: 1221

Group type: COMPARATOR
Intervention: Fresco (low-calorie protein-free beverage)
Number of subjects: 1221
Study: 35068500

Group type: EXPERIMENTAL
Intervention: Bepotastine 10 mg tablet twice daily
Number of subjects: 59

Group type: COMPARATOR
Intervention: Levocetirizine 5 mg tablet once daily
Number of subjects: 59
Study: 33172504

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 7637

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7637
Study: 36203797

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (two capsules containing multi-strain probiotics daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (two capsules daily)
Number of subjects: 70
Study: 36095188

Group type: EXPERIMENTAL
Intervention: High-quality foster care
Number of subjects: 135

Group type: COMPARATOR
Intervention: Care as usual (control)
Number of subjects: 135
Study: 33772877

Group type: EXPERIMENTAL
Intervention: Physical and Cognitive Training (PTCT)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Physical Training (PT)
Number of subjects: 314
Study: 32441759

Group type: EXPERIMENTAL
Intervention: Tumaini smartphone game
Number of subjects: 60
Study: 35381194

Group type: EXPERIMENTAL
Intervention: Low sodium diet (<100 mmol or <1500 mg/day)
Number of subjects: 806

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Low sodium diet
Number of subjects: 806
Study: 34261992

Group type: EXPERIMENTAL
Intervention: High-active group
Number of subjects: 2195

Group type: EXPERIMENTAL
Intervention: Total steps per day tracking
Number of subjects: 2195

Group type: EXPERIMENTAL
Intervention: Aerobic steps per day tracking
Number of subjects: 2195

Group type: EXPERIMENTAL
Intervention: Percentage agreements
Number of subjects: 2195

Group type: EXPERIMENTAL
Intervention: Kappa statistics
Number of subjects: 2195

Group type: EXPERIMENTAL
Intervention: Sex, age, and BMI associations
Number of subjects: 2195
Study: 33196605

Group type: EXPERIMENTAL
Intervention: 50 g KE
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 180 mg·kg‐1 body weight NaHCO3 (BIC)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: KE + BIC
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control drink (CON)
Number of subjects: 14
Study: 34509641

Group type: EXPERIMENTAL
Intervention: High-volume split-dose PEG (2 L + 2 L)
Number of subjects: 2314

Group type: COMPARATOR
Intervention: Low-volume split-dose PEG (1 L + 1 L) + bisacodyl (15 mg)
Number of subjects: 2314
Study: 32012284

Group type: EXPERIMENTAL
Intervention: Alternate light source (ALS) at 415 nm using a yellow filter
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Alternate light source (ALS) at 450 nm using a yellow filter
Number of subjects: 157

Group type: COMPARATOR
Intervention: White light
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Localized fat
Number of subjects: 157
Study: 36445213

Group type: EXPERIMENTAL
Intervention: 1-mm bulb obturator (G1)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 2-mm bulb obturator (G2)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 3-mm bulb obturator (G3)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Weight of obturators
Number of subjects: 17
Study: 34036357

Group type: COMPARATOR
Intervention: Calorie-free control (water)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Skim milk
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Whole milk
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 350 g Greek yogurt
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 60 g cheddar cheese
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Dairy products (overall)
Number of subjects: 58
Study: 34252178

Group type: EXPERIMENTAL
Intervention: 5A's counselling administered by nurses
Number of subjects: 480

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 480
Study: 33476537

Group type: EXPERIMENTAL
Intervention: Total glucosides of paeony (TGP) treatment group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine treatment group
Number of subjects: 64
Study: 32938433

Group type: EXPERIMENTAL
Intervention: Skin to skin contact
Number of subjects: 28121

Group type: EXPERIMENTAL
Intervention: Early initiation of breastfeeding
Number of subjects: 28121

Group type: EXPERIMENTAL
Intervention: Receipt of one element
Number of subjects: 28121

Group type: EXPERIMENTAL
Intervention: Receipt of all four elements
Number of subjects: 28121
Study: 32812478

Group type: EXPERIMENTAL
Intervention: Pain neuroscience education (PNE), manual therapy (MT), and home exercise program (HEP)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT) and home exercise program (HEP)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Home exercise program (HEP)
Number of subjects: 69
Study: 32030863

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36330870

Group type: EXPERIMENTAL
Intervention: Social norms message and outcome expectancy message
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Risk reduction message and response efficacy message
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Discomfort acknowledgement message and support message
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Multiple messages combined
Number of subjects: 475

Group type: COMPARATOR
Intervention: Control group (basic information about cervical screening)
Number of subjects: 475
Study: 32088198

Group type: EXPERIMENTAL
Intervention: Wearing a head‐mounted eye tracker
Number of subjects: 25

Group type: COMPARATOR
Intervention: Eyes closed
Number of subjects: 25

Group type: COMPARATOR
Intervention: Horizontal saccades
Number of subjects: 25
Study: 36028729

Group type: EXPERIMENTAL
Intervention: Brief perceptual training (n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control condition (n=15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Brief perceptual training
Number of subjects: 30
Study: 34362762

Group type: EXPERIMENTAL
Intervention: Automatic oxygen titration using a novel nasal high-flow device
Number of subjects: 20

Group type: COMPARATOR
Intervention: Manual oxygen titration using nasal high flow
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Automatic oxygen titration
Number of subjects: 20
Study: 32539853

Group type: EXPERIMENTAL
Intervention: Immediate initiation of pan-genotypic DAA treatment with individualized follow-up
Number of subjects: 220

Group type: COMPARATOR
Intervention: Standard of care: referral to outpatient care at discharge
Number of subjects: 220
Study: 35778977

Group type: EXPERIMENTAL
Intervention: CMAB008 (infliximab biosimilar)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Infliximab reference product (Remicade)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CMAB008
Number of subjects: 90

Group type: COMPARATOR
Intervention: Infliximab reference product
Number of subjects: 90
Study: 34932079

Group type: EXPERIMENTAL
Intervention: Marine omega-3 fatty acids (1 g/d of fish oil, including 465 mg of eicosapentaenoic acid and 375 mg of docosahexaenoic acid)
Number of subjects: 18353

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18353

Group type: EXPERIMENTAL
Intervention: Marine omega-3 fatty acids (1 g/d of fish oil)
Number of subjects: 18353

Group type: EXPERIMENTAL
Intervention: Marine omega-3 fatty acids
Number of subjects: 18353
Study: 36266551

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS) based on race, histological type, tumor grade, T stage, N stage, carcinoembryonic antigen (CEA) level, and number of lymph nodes (LN) examined.
Number of subjects: 3026

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 3026
Study: 34779063

Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34393178

Group type: EXPERIMENTAL
Intervention: Alcohol-assisted PRK
Number of subjects: 82

Group type: COMPARATOR
Intervention: Mechanical PRK
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 82
Study: 35586670

Group type: EXPERIMENTAL
Intervention: Side-approach laparoscopic splenectomy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Reference group (control)
Number of subjects: 62
Study: 33859330

Group type: EXPERIMENTAL
Intervention: Galacto-oligosaccharides (GOS) prebiotic supplement
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 32613727

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 1413

Group type: COMPARATOR
Intervention: Type 1 diabetes
Number of subjects: 1413
Study: 35580487

Group type: EXPERIMENTAL
Intervention: DRY group cycling at 125‐150W for one hour in a non‐immersed condition (34.4˚C, 50%RH)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: WET group cycling at 50W for one hour while immersed in 34.4˚C water
Number of subjects: 19

Group type: COMPARATOR
Intervention: Comparison of HOT vs WARM water
Number of subjects: 19

Group type: COMPARATOR
Intervention: Rate of Tc rise
Number of subjects: 19

Group type: COMPARATOR
Intervention: Maximum Tc and Tc change from baseline
Number of subjects: 19
Study: 35848700

Group type: EXPERIMENTAL
Intervention: P. oleracea
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32956797

Group type: EXPERIMENTAL
Intervention: Tack Endovascular System
Number of subjects: 233
Study: 36440618

Group type: EXPERIMENTAL
Intervention: Oscillomate 9002
Number of subjects: 82

Group type: COMPARATOR
Intervention: Mindray VS‐900
Number of subjects: 82
Study: 33534909

Group type: EXPERIMENTAL
Intervention: B. sessilis (faster growing)
Number of subjects: 2

Group type: COMPARATOR
Intervention: B. attenuata (slower growing)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Both species
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: B. sessilis
Number of subjects: 2
Study: 32341247

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC) at 250 mm Hg; four 5-minute cycles of ischemia
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham treatment at 20 mm Hg
Number of subjects: 14
Study: 33956130

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg biweekly)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Nivolumab (fixed dose of 240 mg biweekly or 480 mg monthly)
Number of subjects: 487

Group type: COMPARATOR
Intervention: Pembrolizumab
Number of subjects: 487
Study: 33158451

Group type: EXPERIMENTAL
Intervention: Acupoints on the Heart Meridian
Number of subjects: 148

Group type: COMPARATOR
Intervention: Acupoints on the Lung Meridian
Number of subjects: 148
Study: 34417369

Group type: EXPERIMENTAL
Intervention: Modified Collard (MC) technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Circular Stapled (CS) technique
Number of subjects: 100
Study: 34215210

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 501

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 501
Study: 32769818

Group type: EXPERIMENTAL
Intervention: Non-invasive whole-body bio-impedance technology (NiCAS) during phlebotomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 35716058

Group type: EXPERIMENTAL
Intervention: Cooled radiofrequency ablation (CRFA) of genicular nerves
Number of subjects: 36
Study: 32293334

Group type: EXPERIMENTAL
Intervention: 2-week high intensity interval training (HIIT) programme
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard preoperative care
Number of subjects: 78
Study: 36460959

Group type: EXPERIMENTAL
Intervention: Salutogenic Healthy Ageing Programme Embracement (SHAPE) intervention
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 34
Study: 33383182

Group type: EXPERIMENTAL
Intervention: Ca(OH)2 + ciprofloxacin
Number of subjects: 66

Group type: COMPARATOR
Intervention: Ca(OH)2
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ca(OH)2 + ibuprofen
Number of subjects: 66
Study: 35592857

Group type: EXPERIMENTAL
Intervention: 300 mg pregabalin
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 150 mg pregabalin
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 33243815

Group type: EXPERIMENTAL
Intervention: CAP256V2LS administered intravenously
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CAP256V2LS administered subcutaneously with and without rHuPH20
Number of subjects: 0

Group type: COMPARATOR
Intervention: CAP256V2LS+VRC07-523LS administered SC
Number of subjects: 0

Group type: COMPARATOR
Intervention: CAP256V2LS+PGT121 administered SC
Number of subjects: 0

Group type: COMPARATOR
Intervention: CAP256V2LS+VRC07-523LS+PGT121 administered SC
Number of subjects: 0
Study: 34988679

Group type: EXPERIMENTAL
Intervention: Delayed-release formulation of posaconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiologically based pharmacokinetic modeling
Number of subjects: 0
Study: 34058717

Group type: EXPERIMENTAL
Intervention: High sodium diet (7000 mg/d)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Medium sodium diet (2300 mg/d)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low sodium diet (1000 mg/d)
Number of subjects: 10
Study: 32533985

Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer 2-5h after thaw (Group D2)
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer 18-24h after thaw (Group D2/D3)
Number of subjects: 388
Study: 35543540

Group type: EXPERIMENTAL
Intervention: 5 intradetrusor injections of onabotulinumtoxinA
Number of subjects: 0

Group type: COMPARATOR
Intervention: 20 intradetrusor injections of onabotulinumtoxinA
Number of subjects: 0